Advertisement

Journal of General Internal Medicine

, Volume 26, Issue 8, pp 834–840 | Cite as

Genomic Risk Profiling: Attitudes and Use in Personal and Clinical Care of Primary Care Physicians Who Offer Risk Profiling

  • Susanne B. Haga
  • Madeline M. Carrig
  • Julianne M. O’Daniel
  • Lori A. Orlando
  • Ley A. Killeya-Jones
  • Geoffrey S. Ginsburg
  • Alex Cho
Original Research

ABSTRACT

BACKGROUND

Genomic risk profiling involves the analysis of genetic variations linked through statistical associations to a range of disease states. There is considerable controversy as to how, and even whether, to incorporate these tests into routine medical care.

OBJECTIVE

To assess physician attitudes and uptake of genomic risk profiling among an ‘early adopter’ practice group.

DESIGN

We surveyed members of MDVIP, a national group of primary care physicians (PCPs), currently offering genomic risk profiling as part of their practice.

POPULATION

All physicians in the MDVIP network (N = 356)

RESULTS

We obtained a 44% response rate. One third of respondents had ordered a test for themselves and 42% for a patient. The odds of having ordered personal testing were 10.51-fold higher for those who felt well-informed about genomic risk testing (p < 0.0001). Of those who had not ordered a test for themselves, 60% expressed concerns for patients regarding discrimination by life and long-term/disability insurers, 61% about test cost, and 62% about clinical utility. The odds of ordering testing for their patients was 8.29-fold higher among respondents who had ordered testing for themselves (p < 0.0001). Of those who had ordered testing for patients, concerns about insurance coverage (p = 0.014) and uncertain clinical utility (p = 0.034) were associated with a lower relative frequency of intention to order testing again in the future.

CONCLUSIONS

Our findings demonstrate that respondent familiarity was a key predictor of physician ordering behavior and clinical utility was a primary concern for genomic risk profiling. Educational and interpretive support may enhance uptake of genomic risk profiling.

KEY WORDS

primary care genetic testing risk education 

Notes

Acknowledgements

The authors thank Dr. Hunt Willard for his helpful comments on the manuscript and Ms. Genevieve Tindall for her assistance on the project and manuscript. This work was supported in part by The Duke Endowment (Health Care Division) (S.B.H, J.M.O, L.K-J., G.G., A.C.) and National Institute on Drug Abuse (NIDA) Grant P30 DA023026 (M.M.C.). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NIDA.

Conflict of Interest

Duke University has no relationship with MDVIP. The Executive Health program at Duke University Medical Center offers genomic risk assessments to interested patients, including but not limited to tests provided by Navigenics.

Supplementary material

11606_2011_1651_MOESM1_ESM.doc (22 kb)
Online Appendix Details of Survey Population (DOC 22 kb)

References

  1. 1.
    Janssens AC, Gwinn M, Bradley LA, Oostra BA, van Duijn CM, Khoury MJ. A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions. Am J Hum Genet. 2008;82(3):593–599.PubMedCrossRefGoogle Scholar
  2. 2.
    Mihaescu R, van Hoek M, Sijbrands EJ, Uitterlinden AG, Witteman JC, Hofman A, et al. Evaluation of risk prediction updates from commercial genome-wide scans. Genet Med. 2009;11(8):588–594.PubMedCrossRefGoogle Scholar
  3. 3.
    Hunter DJ, Khoury MJ, Drazen JM. Letting the genome out of the bottle–will we get our wish? N Engl J Med. 2008;358(2):105–107.PubMedCrossRefGoogle Scholar
  4. 4.
    Scheuner MT, Sieverding P, Shekelle PG. Delivery of genomic medicine for common chronic adult diseases: a systematic review. JAMA. 2008;299(11):1320–1334.PubMedCrossRefGoogle Scholar
  5. 5.
    Paynter NP, Chasman DI, Pare G, Buring JE, Cook NR, Miletich JP, et al. Association between a literature-based genetic risk score and cardiovascular events in women. JAMA. 2010;303(7):631–637.PubMedCrossRefGoogle Scholar
  6. 6.
    Talmud PJ, Hingorani AD, Cooper JA, Marmot MG, Brunner EJ, Kumari M, et al. Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study. BMJ. 2010;340:b4838.PubMedCrossRefGoogle Scholar
  7. 7.
    Bentley P, Peck G, Smeeth L, Whittaker J, Sharma P. Causal relationship of susceptibility genes to ischemic stroke: comparison to ischemic heart disease and biochemical determinants. PLoS ONE. 2010;5(2):e9136.PubMedCrossRefGoogle Scholar
  8. 8.
    Meigs JB, Shrader P, Sullivan LM, McAteer JB, Fox CS, Dupuis J, et al. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med. 2008;359(21):2208–2219.PubMedCrossRefGoogle Scholar
  9. 9.
    Lyssenko V, Jonsson A, Almgren P, Pulizzi N, Isomaa B, Tuomi T, et al. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med. 2008;359(21):2220–2232.PubMedCrossRefGoogle Scholar
  10. 10.
    Lango H, Consortium UKTDG, Palmer CN, Morris AD, Zeggini E, Hattersley AT, et al. Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk. Diabetes. 2008;57(11):3129–3135.PubMedCrossRefGoogle Scholar
  11. 11.
    Marquezine GF, Pereira AC, Sousa AG, Mill JG, Hueb WA, Krieger JE. TCF7L2 variant genotypes and type 2 diabetes risk in Brazil: significant association, but not a significant tool for risk stratification in the general population. BMC Med Genet. 2008;9:106.PubMedCrossRefGoogle Scholar
  12. 12.
    Hunter A, Wright P, Cappelli M, Kasaboski A, Surh L. Physician knowledge and attitudes towards molecular genetic (DNA) testing of their patients. Clin Genet. 1998;53(6):447–455.PubMedCrossRefGoogle Scholar
  13. 13.
    Menasha JD, Schechter C, Willner J. Genetic testing: a physician’s perspective. Mt Sinai J Med. 2000;67(2):144–151.PubMedGoogle Scholar
  14. 14.
    Metcalfe S, Hurworth R, Newstead J, Robins R. Needs assessment study of genetics education for general practitioners in Australia. Genet Med. 2002;4(2):71–77.PubMedCrossRefGoogle Scholar
  15. 15.
    Baars MJ, Henneman L, Ten Kate LP. Deficiency of knowledge of genetics and genetic tests among general practitioners, gynecologists, and pediatricians: a global problem. Genet Med. 2005;7(9):605–610.PubMedCrossRefGoogle Scholar
  16. 16.
    Wideroff L, Vadaparampil ST, Greene MH, Taplin S, Olson L, Freedman AN. Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. J Med Genet. 2005;42(10):749–755.PubMedCrossRefGoogle Scholar
  17. 17.
    Burke W, Psaty B. Personalized medicine in the era of genomics. J Am Med Assoc. 2007;298(14):1682–1684.CrossRefGoogle Scholar
  18. 18.
    Navigenics. Navigenics MDVIP Physician and Staff Training. 2010 [accessed January 20, 2011]; Available from: http://www.navigenics.com/partners/mdvip_training.
  19. 19.
    Shields AE, Burke W, Levy DE. Differential use of available genetic tests among primary care physicians in the United States: results of a national survey. Genet Med. 2008;10(6):404–414.PubMedCrossRefGoogle Scholar
  20. 20.
    Suchard MA, Yudkin P, Sinsheimer JS, Fowler GH. General practitioners’ views on genetic screening for common diseases. Br J Gen Pract. 1999;49(438):45–46.PubMedGoogle Scholar
  21. 21.
    Wideroff L, Freedman AN, Olson L, Klabunde CN, Davis W, Srinath KP, et al. Physician use of genetic testing for cancer susceptibility: results of a national survey. Cancer epidemiol biomark prev. 2003;12(4):295–303.Google Scholar
  22. 22.
    Grant RW, Hivert M, Pandiscio JC, Florez JC, Nathan DM, Meigs JB. The clinical application of genetic testing in type 2 diabetes: a patient and physician survey. Diabetologia. 2009 Sep 2.Google Scholar
  23. 23.
    Shields AE, Blumenthal D, Weiss KB, Comstock CB, Currivan D, Lerman C. Barriers to translating emerging genetic research on smoking into clinical practice. Perspectives of primary care physicians. J Gen Intern Med. 2005;20(2):131–138.PubMedCrossRefGoogle Scholar
  24. 24.
    Frank E, Tong E, Lobelo F, Carrera J, Duperly J. Physical activity levels and counseling practices of U.S. medical students. Med Sci Sports Exerc. 2008;40(3):413–421.PubMedCrossRefGoogle Scholar
  25. 25.
    Lobelo F, Duperly J, Frank E. Physical activity habits of doctors and medical students influence their counselling practices. Br J Sports Med. 2009;43(2):89–92.PubMedCrossRefGoogle Scholar
  26. 26.
    Frank E, Rothenberg R, Lewis C, Belodoff BF. Correlates of physicians’ prevention-related practices. Findings from the Women Physicians’ Health Study. Arch Fam Med. 2000;9(4):359–367.PubMedCrossRefGoogle Scholar
  27. 27.
    Cherkas LF, Harris JM, Levinson E, Spector TD, Prainsack B. A survey of UK public interest in Internet-based personal genome testing. PLoS ONE. 2010;5(10):e13473.PubMedCrossRefGoogle Scholar
  28. 28.
    McGuire AL, Diaz CM, Wang T, Hilsenbeck SG. Social networkers’ attitudes toward direct-to-consumer personal genome testing. Am J Bioeth. 2009;9(6–7):3–10.PubMedGoogle Scholar
  29. 29.
    Kolor K, Liu T, St Pierre J, Khoury MJ. Health care provider and consumer awareness, perceptions, and use of direct-to-consumer personal genomic tests, United States, 2008. Genet Med. 2009;11(8):595.PubMedCrossRefGoogle Scholar
  30. 30.
    O’Daniel JM, Haga SB, Willard HF. Considerations for the impact of personal genome information: a study of genomic profiling among genetics and genomics professionals. J Genet Couns. 2010;19(4):387–401.PubMedCrossRefGoogle Scholar
  31. 31.
    Green RC, Roberts JS, Cupples LA, Relkin NR, Whitehouse PJ, Brown T, et al. Disclosure of APOE genotype for risk of Alzheimer’s disease. N Engl J Med. 2009;361(3):245–254.PubMedCrossRefGoogle Scholar
  32. 32.
    Bloss CS, Ornowski L, Silver E, Cargill M, Vanier V, Schork NJ, et al. Consumer perceptions of direct-to-consumer personalized genomic risk assessments. Genet Med. 2010;12(9):556–566.PubMedCrossRefGoogle Scholar
  33. 33.
    Hensley Alford S, McBride CM, Reid RJ, Larson EB, Baxevanis AD, Brody LC. Participation in Genetic Testing Research Varies by Social Group. Public Health Genomics. 2010 Mar 18.Google Scholar
  34. 34.
    Goddard KA, Moore C, Ottman D, Szegda KL, Bradley L, Khoury MJ. Awareness and use of direct-to-consumer nutrigenomic tests, United States, 2006. Genet Med. 2007;9(8):510–517.PubMedCrossRefGoogle Scholar
  35. 35.
    Escher M, Sappino AP. Primary care physicians’ knowledge and attitudes towards genetic testing for breast-ovarian cancer predisposition. Ann Oncol. 2000;11(9):1131–1135.PubMedCrossRefGoogle Scholar
  36. 36.
    Mountcastle-Shah E, Holtzman NA. Primary care physicians’ perceptions of barriers to genetic testing and their willingness to participate in research. Am J Med Genet. 2000;94(5):409–416.PubMedCrossRefGoogle Scholar
  37. 37.
    Freedman AN, Wideroff L, Olson L, Davis W, Klabunde C, Srinath KP, et al. US physicians’ attitudes toward genetic testing for cancer susceptibility. Am J Med Genet A. 2003;120A(1):63–71.PubMedCrossRefGoogle Scholar
  38. 38.
    Levy DE, Youatt EJ, Shields AE. Primary care physicians’ concerns about offering a genetic test to tailor smoking cessation treatment. Genet Med. 2007;9(12):842–849.PubMedCrossRefGoogle Scholar
  39. 39.
    Park ER, Kleimann S, Pelan JA, Shields AE. Anticipating clinical integration of genetically tailored tobacco dependence treatment: perspectives of primary care physicians. Nicotine Tob Res. 2007;9(2):271–279.PubMedCrossRefGoogle Scholar
  40. 40.
    ACGME. ACGME Program Requirements for Graduate Medical Education in Family Medicine2007. [accessed January 20, 2011]; Available from: http://www.acgme.org/acWebsite/downloads/RRC_progReq/120pr07012007.pdf.
  41. 41.
    Mrazek M, Koenig B, Skime M, Snyder K, Hook C, Black J 3rd, et al. Assessing attitudes about genetic testing as a component of continuing medical education. Acad Psychiatry. 2007;31(6):447–451.PubMedCrossRefGoogle Scholar
  42. 42.
    Clyman JC, Nazir F, Tarolli S, Black E, Lombardi RQ, Higgins JJ. The impact of a genetics education program on physicians’ knowledge and genetic counseling referral patterns. Med Teach. 2007;29(6):e143–e150.PubMedCrossRefGoogle Scholar
  43. 43.
    Carroll JC, Rideout AL, Wilson BJ, Allanson JM, Blaine SM, Esplen MJ, et al. Genetic education for primary care providers: improving attitudes, knowledge, and confidence. Can Fam Physician. 2009;55(12):e92–e99.PubMedGoogle Scholar

Copyright information

© Society of General Internal Medicine 2011

Authors and Affiliations

  • Susanne B. Haga
    • 1
    • 4
  • Madeline M. Carrig
    • 2
  • Julianne M. O’Daniel
    • 1
  • Lori A. Orlando
    • 3
  • Ley A. Killeya-Jones
    • 1
  • Geoffrey S. Ginsburg
    • 1
    • 3
  • Alex Cho
    • 1
    • 3
  1. 1.Duke Institute for Genome Sciences & PolicyDuke UniversityDurhamUSA
  2. 2.Department of Psychology and NeuroscienceDuke UniversityDurhamUSA
  3. 3.Department of MedicineDuke UniversityDurhamUSA
  4. 4.Institute for Genome Sciences & Policy, and Sanford School of Public PolicyDuke UniversityDurhamUSA

Personalised recommendations